Skip to main content
BMJ Open logoLink to BMJ Open
. 2023 Oct 26;13(10):e075038. doi: 10.1136/bmjopen-2023-075038

Scabies in the Amhara region of northern Ethiopia: a cross-sectional study of prevalence, determinants, clinical presentation and community knowledge

Robel Yirgu 1,2,3,, Jo Middleton 2,4,5, Abebaw Fekadu 2,3, Jackie A Cassell 2,5, Abraham Tesfaye 3, Christopher Iain Jones 5, Stephen Bremner 2,5, Wendemagegn Enbiale 6, Gail Davey 1,2
PMCID: PMC10603513  PMID: 37880172

Abstract

Background

The WHO aims to prevent, eliminate or control neglected tropical diseases, including scabies, by 2030. However, limited epidemiological data presented a challenge to control efforts, especially in high burden countries. There was a major scabies outbreak in northern Ethiopia starting in 2015 and prevalence has since increased across much of the country.

Objective

To estimate scabies prevalence, identify its predictors, and assess community perception of, and knowledge about, the infestation.

Design

Population-based cross-sectional study.

Study setting

Ayu Guagusa district, Amhara region, northern Ethiopia.

Participants

1437 people who were members of 381 randomly selected households participated in the study. Five trained mid-level health workers clinically diagnosed people with scabies.

Outcome measures

Clinically diagnosed scabies infestation.

Data analysis

Multi-level logistic regression models were fitted to adjust for individual and household-level confounding variables, and identify predictors of scabies infestation.

Results

Scabies prevalence was 13.4% (95% CI 11.8 to 15.5). Households of more than five people (adjusted OR (aOR)=3.5, 95% CI 1.2 to 10.2) were associated with increased odds of developing scabies, however, females had lower odds (aOR=0.5 95% CI 0.3 to 0.8). Scabietic lesions most frequently involved the trunk (62.0%), and vesicles were the most common types of lesions (67.7%). Two-thirds of adult study participants had heard about scabies and most obtained scabies related information from informal sources. Only 32% of cases sought care for scabies from any source.

Conclusion

Scabies prevalence was high, signifying the need for community-based control interventions. Host density and sex were important predictors of scabies. Despite the favourable attitude toward the effectiveness of scabies treatment, healthcare seeking was low.

Keywords: epidemiology, infectious diseases & infestations, public health, neglected diseases, dermatological epidemiology


STRENGTHS AND LIMITATIONS OF THE STUDY.

  • The clinical diagnosis that we employed in this study cannot detect cases in the asymptomatic incubation period.

  • Physical examination of participants did not involve private body parts and we might have missed some people with scabies.

  • Single dose ivermectin-only mass drug administration against onchocerciasis had been underway in the study district. This could have treated scabies cases, undermining the true prevalence.

  • Though in our model, household size predicted increased odds of scabies, we could not objectively attribute this to host density, as we neither measured the size of housing units nor assessed sleeping arrangements.

Introduction

The WHO aims to prevent, eliminate or control neglected tropical diseases (NTDs) by 2030.1 Achieving this is contingent on availability of epidemiological data on NTD burden and distribution.2 However, due to long standing neglect we know little about the epidemiology of many NTDs, including scabies, especially in high-burden low-income settings.3

Scabies is a skin infestation caused by the mite Sarcoptes scabiei,4 which is established after a pregnant female burrows into the epidermis.4 5 The average number of burrowing mites on an individual human host ranges between 10 and 15 but severe infestations of ‘crusted scabies’ (which are less common), can involve thousands of mites on an individual host.6 Typical manifestations include generalised itch, rash and contact history with a presumed scabies patient.7 8 Burrows are pathognomonic but rarely identified before thorough physical examination by experienced practitioners.8 Presentation can also include pustules, nodules, chronic excoriation and skin crust.9 Though itch and sleep deprivation are the primary complications of scabies, secondary bacterial infections are associated with cellulitis, fasciitis, septicaemia, acute glomerulonephritis and rheumatic heart disease.6 10 11 Clinical diagnosis is the most frequently used approach in clinical and field settings, though accuracy relies heavily on examiners’ knowledge and experience of scabies.12

Scabies accounts for an estimated 0.21% of disability-adjusted life-years, globally.13 Prolonged physical contact is the main mode of scabies transmission, and circumstances that promote crowding predict increased transmission risk.14 15 Outbreaks are thus common in institutional settings such as prisons, residential care homes for elderly people, hospitals and refugee camps.15 16 Among individual level characteristics, age (children, adolescents and the elderly), low socioeconomic status and travel history to areas of higher scabies prevalence have been identified as increasing risk of developing scabies.12 17 Facility-based studies rank scabies among the top three to five diseases in dermatology clinics.18 19 On the other hand, community-based studies still indicate a pervasive need for scabies care and a significant delay to care seeking.20 21 Limited geographic and financial access to healthcare services, lack of knowledge about the disease and treatment, and stigma and discrimination against scabies patients can contribute to untimely care seeking.19 21 22

Ethiopia reported a major scabies outbreak in 2015.23 Studies conducted between 2015 and 2017 in the northern and southern parts of the country indicated a prevalence ranging between 11% and 33%.23–26 This marked a significant increase from the 4% to 7% estimates in pre-outbreak facility-based studies.26–28 Paucity of population-based data on the pattern and drivers of the outbreak has hindered the design of effective control interventions. In this study, we aimed to determine the epidemiology of scabies in Ayu Guagusa district and characterise the community’s knowledge and perceptions of the infestation.

Methods

Study design and setting

We conducted this cross-sectional study in Ayu Guagusa district, Amhara region, northern Ethiopia in December 2018. As well as determining scabies epidemiology and community knowledge and attitudes, it was designed to function as a baseline for longitudinal research measuring the secondary impact on scabies prevalence of single dose ivermectin-only mass drug administration (MDA).29 The Ethiopian nation state is administratively divided into eleven regional states and two metropolitan councils, with regions subdivided into zones, districts and then kebeles (the lowest administrative unit comprising 3000–5000 people).30 The state then organises households in each kebele into Gotes, small villages holding semi-official positions in the administrative structure. Amhara is the second most populous region with 17 million people, 85% of whom draw livelihoods from rain-dependent agriculture.31 32 The Ethiopian state healthcare system is a three-tier system. Primary healthcare units provide disease prevention and health promotion and comprise a primary hospital, health centre and five satellite health posts. General hospitals provide secondary level care, with specialised and teaching hospitals serving as centres for tertiary specialised care. Health centre staff are mid-level health workers, trained to provide care for patients who do not require advanced medical attention. Health posts are the closest state health facilities to most communities, one post serves 3000–5000 people. Health posts are staffed with two health extension workers (HEWs), who provide primary healthcare services and facility patient referrals.30

Sampling procedure

We selected northern Ethiopia for this study as we aimed to investigate the scabies outbreak in the region. Ayu Guagusa district (online supplemental figure S1) was purposively selected as it was the only district, among 11 other districts in Awi zone of Amhara region, in which MDA to eliminate onchocerciasis was underway. There are 21 kebeles in the district. Six were selected for this study by using simple random sampling. The number of kebeles is determined by dividing the sample size to the average size of kebele population (3000–5000). Then, one gote (small village) was randomly selected from each kebele. A sampling frame comprising a list of households in the selected gotes was prepared. Simple random sampling was employed to select study households from the frame. Eventually, all consenting members of selected households participated in the study.

Supplementary data

bmjopen-2023-075038supp001.pdf (682.4KB, pdf)

Data collection

Sociodemographic characteristics, healthcare seeking for scabies manifestations, contact history with a person showing scabies-suggestive symptoms, taking ivermectin tablets during the last round of MDA against onchocerciasis, and knowledge of and attitude toward scabies were measured at the level of the individual participants. Household wealth, household size and keeping domestic animals in the homestead were measured at the household level.

Data collection instruments and procedures

An interview questionnaire was used to collect data from adult study participants, and parents or guardians of children aged <15 years (online supplemental table S1). After the tool was translated to the local language, Amharic, we pretested it with 12 people selected from a kebele near to the study district.

Clinical diagnosis was employed to identify scabies cases. Classic manifestations such as itch, skin rash with typical distribution and contact history with a person exhibiting scabies symptoms were considered.12 Clinical examination with naked eye was carried out in sufficiently illuminated rooms in participants’ residences. During examination most parts of the body were exposed except the genitals and breasts. A chaperone was present for examinations of participants <18 years. Four nurses and one health officer, who were clinical staff in the nearby primary hospital, conducted the clinical examinations. These had prior experience identifying scabies patients in-clinics and were given a 3-day refresher training on scabies diagnosis by a dermatovenerologist (coauthor WE) from Bahir Dar University. The training aimed to standardise characterisation of disease manifestations and minimise interobserver bias in diagnosing scabies. Additionally, during the first few days of the field work, data collectors sent every participant identified as a scabies patient to the dermatologist. At times when there were disagreements in diagnosis, WE discussed the case with the data collectors and the consensual diagnosis was taken.

Sample size

We considered an average household size of rural communities as four and intraclass correlation coefficient of 0.733 to calculate a design effect of 3.1. Including 15% non-participation rate we needed to involve 1210 people to detect 33% scabies prevalence with 5% precision. This sample size is also sufficient to fit multi-level logistic regression models with >10 variables while maintaining an event per variable ratio of >10.

Data processing and analysis

An electronic template was prepared using Epidata V.3.01 (EpiData Association, Odense) statistical software to enter data from the paper-based questionnaire. Data were later exported to Stata V.14.0 (StataCorp LLC, Texas) for analysis. Summary measures were calculated for categorical data (frequency and percentage) and continuous data (mean and SD or median and IQR). Study households were categorised into wealth quintiles factoring in ownership of fixed household assets. Principal component analysis was used to generate components which best captured variability in wealth between the study households. Twenty-six binary variables of household asset and livestock ownership (including access to infrastructure) were included in the analysis (online supplemental table S2) and no significant correlation was observed among these covariates. Twenty-two principal components were generated with varimax rotation, and the first component, which had the highest eigen value, was used to generate the wealth index.

The dataset was hierarchical at two levels (ie, household and individual household member), and there was a high possibility for observations among members of the same household to be correlated. The intra-class correlation coefficient (ICC) was used to characterise the level of correlation between observations from the same household. The ICC was 0.88 (95% CI 0.79 to 0.94), indicating a significant cluster effect between members of the same study household, justifying the multi-level modelling approach. We thus fitted multi-level logistic regression models to calculate the independent effects of individual and household level predictors on the odds of developing scabies. The models included individual participant level variables (ie, age, sex, marital status, level of education, occupation, contact history with a person exhibiting signs of scabies, bathing and participating in the last round of MDA) and three household level variables (ie, household size, presence of domestic animals in the homestead and household wealth) and a random effect for household.

We applied the melogit stata command to fit the models and calculate adjusted OR (aOR), with 95% CI to determine the strength and direction of association between the dependent and the predictor variables. Variable inflation factors (VIFs) were calculated to detect multicollinearity among the predictor variables, but none were dropped from the model as all the VIF values were less than 5.

Patient and public involvement

People affected by podoconiosis, a non-infectious lymphoedema caused by prolonged exposure of the feet to irritant soil, another heavily neglected tropical condition, were involved in the development of the funding proposal supporting this study. However, at that point in time (2016), there was no scabies patient association in existence in Ethiopia. Subsequent proposals have included input from people affected by scabies, through proposal development workshops and a newly established community of practice.

Results

Participants

Across six kebeles, a total of 1437 people (797 females, 640 males) out of 1833 registered members of the 381 study households participated. Three hundred and ninety-six people were excluded after data collectors reported failure to find them after three subsequent visits to their households (online supplemental figure S2). All members of the selected households approached for recruitment consented to participate. This may surprise some readers. However, high consent rates are not uncommon in medical research in rural Ethiopian communities.34 35 This may be explained by the community’s respect for and trust of health workers and the frequent routine contact communities have with HEWs when they are doing outreach.36

Median age was 19 years (range, 10–37 years) (table 1). Almost half the participants (49.5%) were ≤18 years, 30.3% were 19–40 years, but, broadly in line with Ethiopia’s demographics,34 20.3% were ≥41 years (compared with 16% of the national population). Most did not have a formal education (59.7%) and only 7% of participants had secondary level or above education. The most common occupational group was farming (52.2%), followed by being a student (47.8%). Most participants ≥16 years were married (38.8% of total participants). The number of households with a household size of <5 (49.2%) and ≥5 (50.8%) was similar. Most study households (70.6%) always used surface water for any purpose. 26.6% of participants reported bathing less than weekly, 54.9% reported bathing 1–2 times weekly, and 18.5% ≥3 times weekly. 13.9% of interviewees stated their clothes were washed less than once per week, 77.7% 1–2 times weekly and 8.5% ≥3 times weekly. Median time for a round trip to water source was 20 min.

Table 1.

Socioeconomic characteristics of the study sample (n=1437)

Variables Categories Overall
(n=1437) n (%)
Scabies diagnosis
No scabies manifestations
(n=1245) n (%)
Clinical scabies
(n=192) n (%)
Sex Male 640 (44.5) 539 (43.3) 101 (52.6)
Female 797 (55.5) 706 (56.7) 91 (47.4)
Age in years ≤10 365 (25.4) 316 (25.4) 49 (25.5)
11–18 346 (24.1) 287 (23.1) 59 (30.7)
19–40 435 (30.3) 387 (31.1) 48 (25.0)
≥41* 291 (20.3) 255 (20.5) 36 (18.8)
Median age (IQR) 19 (10–37) 20 (10–38) 16 (10–30)
Level of education† (n=1422) No formal education 849 (59.7) 745 (60.6) 104 (54.2)
Primary education 474 (33.3) 401 (32.6) 73 (38.0)
Secondary and above 99 (7.0) 84 (6.8) 15 (7.8)
Occupation
(n=1412)
Farmer 737 (52.2) 650 (53.3) 87 (45.3)
Student 675 (47.8) 570 (46.7) 105 (54.7)
Marital status‡ Not married 228 (15.9) 204 (16.4) 24 (12.5)
Married 558 (38.8) 487 (39.1) 71 (37.0)
<16 years 651 (45.3) 554 (44.5) 97 (50.5)
Household size <5 people 707 (49.2) 637 (51.2) 70 (36.5)
≥5 people 730 (50.8) 608 (48.8) 122 (63.5)
Contact history with symptomatic person No 947 (65.9) 939 (75.4) 8 (4.2)
Yes 490 (34.1) 306 (24.6) 184 (95.8)
Took pill during the last mass drug administration No 338 (23.5) 274 (22.0) 64 (33.3)
Yes 1099 (76.5) 971 (78.0) 128 (66.7)
Domestic animals kept in the homestead No 202 (14.1) 171 (13.7) 31 (16.2)
Yes 1235 (85.9) 1074 (86.3) 161 (83.9)
Household wealth Lowest 291 (20.3) 266 (21.4) 25 (13.0)
Second 277 (19.3) 240 (19.3) 37 (19.3)
Middle 293 (20.4) 255 (20.5) 38 (19.8)
Fourth 293 (20.4) 261 (20.9) 32 (16.7)
Highest 283 (19.7) 223 (17.9) 60 (31.3)
Main source of water for any purpose§ Public tap 181 (12.6) 139 (11.3) 42 (21.9)
Dug well 405 (28.2) 355 (28.5) 50 (26.0)
Spring water 850 (59.2) 746 (59.9) 104 (54.2)
Frequency of bathing per week <1 382 (26.6) 326 (26.2) 56 (29.2)
1–2 789 (54.9) 688 (55.3) 101 (52.6)
≥3 266 (18.5) 231 (18.6) 35 (18.2)
Frequency of washing clothes per week <1 199 (13.9) 174 (13.9) 25 (13.0)
1–2 1116 (77.7) 967 (77.7) 149 (77.6)
≥3 122 (8.5) 104 (8.4) 18 (9.4)

*People >40 years comprises just 16% of the Ethiopian population.

†This category comprised people with no formal education and children younger than school age.

‡Marital status of participants was only asked of those >16 years.

§Total scores exceed 100% as individual participants could select multiple response categories.

Scabies cases

Scabies prevalence was 13.4% (95% CI 11.8% to 15.5%). The highest age specific prevalence was among people aged 11–18 years 17.1% (95% CI 13.1% to 21.0%) and the lowest among those between 31 and 40 years 6.7% (95% CI 2.9% to 10.6%). The prevalence among people in the extremes of age: 0–10 years and people older than 41 years was 13.4% (95% CI 9.9% to 16.9%) and 12.4% (95% CI 8.6% to 16.2%), respectively. The socioeconomic characteristics and scabies diagnoses of those examined are provided in table 1. One hundred and ninety-two participants had scabies (101 females, 91 males) (online supplemental table S3). Participants with clinical scabies were younger (median 16 years, IQR 10–30 years) than those without signs and symptoms (median 20 years, IQR 10–38 years). Those with no scabies manifestations were evenly split between households with <5 and ≥5 people (respectively: 707, 49.2%; 730, 50.8%), whereas a markedly higher proportion of scabies cases lived in households with ≥5 people (122, 63.5%) than <5 (70, 36.5%). Stated frequency of clothes washing and personal bathing were similar between the scabies cases and those without manifestations.

Clinical presentations of identified scabies cases (n=192) are summarised in online supplemental table S4. Vesicles were the most frequently found clinical signs (67.7%). The trunk and head were the most (62.0%) and least (3.6%) involved body parts. Nearly all individuals diagnosed with scabies (184, 95.8%) reported experiencing itch and the majority (165, 85.9%) stated they had a contact history with a presumed scabies case, most stating they believed they had become infested due to contact with a household member (146, 80.7%). Out of the 192 clinical scabies cases, only 62 (32.3%) reported seeking care by the time the data were collected. Of those that did, the majority (40, 64.5%) reported seeking care from a health facility, while a smaller proportion had carried out self-treatment (14, 22.6%). Three (4.8%) said they had used holy water as a remedy. The median number of days between the onset of symptoms and seeking treatment was 20 (IQR 7–30) (online supplemental table S5). Twenty-seven participants said they sought treatment later than this, giving the following reasons: 21 (77.8%) because they assumed the signs and symptoms would disappear on their own, 3 (11.1%) due to lack of time to seek care, 2 (7.1%) believed medical expenses would be high and 2 (7.1%) because they considered the symptoms mild.

Community knowledge and attitudes about scabies

The knowledge and attitudes of adult study participants are summarised in tables 2 and 3. Two-thirds (n=500) reported they had heard about scabies. When asked how they believed scabies was transmitted, most stated beliefs in line with established scientific knowledge: prolonged physical contact (57.6%); sharing clothes and bedding with a scabies patient (51.4%); sharing sleeping space with a scabies patient (42.4%). However, some stated modes of transmission not in line with scientific understanding: via contaminated water (10.0%); via blood contact (4.0%); from the soil (2.8%). Most said they wanted to know more about the disease, with a higher proportion interested among the scabies cases. When asked to choose from a list, most (93%) selected body creams and anti-scabies tablets as scabies treatments, while small minorities chose holy water (4.4%), traditional treatment (home remedies and traditional herbs) (3.4%) or prayer (1.4%). 56.3% of adults without scabies said they thought any community member could acquire scabies (table 2). Nearly all (441, 95.7%) said they would seek care from healthcare facilities if they developed scabies (table 3). Two hundred and thirteen (48.3%) reported they would feel nothing emotionally if they developed scabies, but 116 (26.3%) said they would feel shame, and 113 (25.6%) fear. When asked to choose from a list of potential attitudes towards scabies patients, a similar proportion chose a response stating, ‘they felt compassion and wanted to help’ and ‘they feared they would be infected by them’ (respectively, 115, 56.4% and 104, 51.0%). One hundred and sixty-six (81.4%) chose a response stating, ‘they believed their community would prefer to avoid scabies patients’, and 46 (22.5%) that ‘people would appear friendly but wish to avoid them’ (table 3).

Table 2.

Knowledge of adult study participants about scabies (n=500)

Variable Categories Overall
n (%)*
Scabies diagnosis among adults
No scabies
manifestations (n=430) n (%)
Clinical scabies (n=70) n (%)
From what sources first heard about scabies Family and friends 320 (64.0) 269 (62.6) 51 (72.9)
Healthcare providers 71 (14.2) 65 (15.1) 6 (8.6)
Health extension workers 48 (9.6) 9 (2.9) 39 (55.7)
Mass media 44 (8.8) 33 (7.7) 11 (15.7)
Religious leaders 18 (3.6) 18 (4.2) 0
Not collected 44 (8.8) 42 (9.8) 2 (2.9)
What are the manifestations of scabies? Itch 449 (89.8) 382 (88.8) 67 (95.7)
Rash 242 (48.4) 187 (43.5) 55 (78.6)
Skin crust 24 (4.8) 17 (3.9) 7 (10.0)
How is scabies transmitted? Prolonged physical contact with a scabies patient 288 (57.6) 245 (56.9) 43 (61.4)
Sharing clothing and bedding with a scabies patient 257 (51.4) 216 (50.2) 41 (58.6)
Sharing sleeping space with scabies patient 212 (42.4) 175 (40.7) 37 (52.9)
From contaminated water 50 (10.0) 49 (11.4) 1 (1.4)
Blood contact with a scabies patient 20 (4.0) 18 (4.2) 2 (2.9)
From the soil 14 (2.8) 12 (2.8) 2 (2.9)
No response 58 (11.6) 49 (11.4) 9 (12.9)
Is scabies treatable? Yes 450 (90.0) 387 (90.0) 63 (90.0)
No 45 (9.0) 39 (9.1) 6 (8.6)
No response 5 (1.0) 4 (1.0) 1 (1.4)
What is the treatment for scabies? Body creams and tablets 469 (93.8) 404 (93.9) 65 (92.8)
Holy water 22 (4.4) 21 (4.9) 1 (1.4)
Traditional treatment 17 (3.4) 16 (3.7) 1 (1.4)
Who can catch scabies? Any one 282 (56.3) 235 (54.5) 47 (67.1)
Poor people 53 (10.6) 42 (9.7) 11 (15.7)
Rich people 14 (2.8) 11 (2.6) 3 (4.3)
Homeless people 24 (4.8) 20 (4.6) 4 (5.7)
Urban people 14 (2.8) 12 (2.8) 2 (2.9)
Rural people 49 (11.1) 38 (10.1) 11 (16.9)
Commercial sex workers 22 (4.4) 19 (4.4) 3 (4.3)
Prisoners 22 (4.4) 18 (4.2) 4 (5.7)
No response 44 (8.8) 39 (9.1) 5 (7.1)
Do you wish to know more about scabies? Yes 435 (87.0) 371 (86.3) 64 (91.4)
No 65 (13.0) 59 (13.7) 6 (8.6)

*Total scores may exceed 100% for some questions when individual participants could select more than one response categories.

Table 3.

Attitude of adult study participants without scabies symptoms towards scabies (n=441)

Question Categories n (%)*
Do you think you can acquire scabies? Yes 265 (61.0)
No 169 (38.3)
No response 7 (1.6)
What would you feel if you developed scabies? Nothing 213 (48.3)
Shame 116 (26.3)
Fear 113 (25.6)
Disappointment 68 (15.4)
Surprise 16 (3.6)
No response 13 (2.9)
What would you do if you developed scabies? Seek care from healthcare facilities 422 (95.7)
Use traditional medicine 2 (0.5)
Do nothing because it improves on its own 2 (0.5)
No response 16 (3.6)
What is your feeling towards scabies patients? (n=204)† I feel compassion and wish to help 115 (56.4)
I fear they may infect me 104 (51.0)
I do not feel anything 66 (32.4)
I feel compassion but prefer to stay away 40 (19.4)
No response 6 (2.9)
How does the community treat scabies patients? (n=204)† Most people prefer to avoid scabies patients 166 (81.4)
People help and support them 78 (38.2)
People appear friendly but they wish they avoided them 46 (22.5)
No response 25 (22.3)

*All items in this table were multiselect and participants could give more than one response for each variable, and this might cause the cumulative score of some variables to exceed the total number of participants.

†Calculated out of 204 participants who have knowledge of a scabies patient.

Odds of infestation

Table 4 gives the results of the multi-level logistic regression analysis of determinants of scabies infestation. The odds of scabies infestation was lower among females (aOR=0.5, 95% CI 0.3 to 0.8), and people from households of five or more had higher odds of infestation (aOR=3.5, 95% CI 1.2 to 10.2). The following were not predictive of scabies diagnosis: occupation; education; marital status; age; frequency of bathing; taking ivermectin tablets during prior MDA; keeping domestic animals in the homestead; household wealth.

Table 4.

Multi-level logistic regression analysis results of determinants of scabies infestation

Variable Category Adjusted OR 95% CI
Sex Male (ref)
Female 0.5 0.3 to 0.8
Age (years) ≤17 (ref)
18–40 0.5 0.0 to 4.4
≥41 0.4 0.0 to 4.2
Occupation Farmer (ref)
Student 0.9 0.3 to 3.2
Education No formal education (ref)
Primary education 1.1 0.5 to 2.3
Secondary and higher 2.8 0.8 to 9.9
Marital status Not married (ref)
Married 0.8 0.1 to 7.0
<16 1.3 0.5 to 3.8
Frequency of bathing per week <1 (ref)
1–2 times 0.6 0.3 to 1.4
≥3 times 1.0 0.3 to 2.9
Took ivermectin during last mass drug administration No (ref)
Yes 0.7 0.2 to 3.0
Household size <5 people (ref)
≥5 people 3.5 1.2 to 10.2
Domestic animals kept in homestead No (ref)
Yes 0.7 0.2 to 3.0
Household wealth Lowest (ref)
Second 0.6 0.1 to 2.7
Middle 0.8 0.2 to 4.1
Fourth 0.8 0.2 to 4.2
Highest 3.5 0.8 to 15.1
Intracluster correlation coefficient
(ICC, 95% CI)
0.89 0.79 to 0.94

Number of households, N=381; number of participants, N=1403; number of cases 192.

Discussion

Scabies prevalence in Ayu Guagusa district was high. Vesicles, excoriations and papules, often involving the trunk, were the most frequently observed signs, and nearly all participants complained of generalised itch. Only around a third of clinical scabies cases had sought care, with the median number of days before seeking care for the minority who did being 20 days. More than two-thirds had heard about scabies, and friends and family were the most common sources of scabies-related information. Most believed scabies was transmitted through prolonged physical contact with a scabies patient and that it could be treated with drugs. In the multi-level logistic regression model being from households of size >5 people increased odds of scabies infestation but female sex was associated with lower odds of scabies.

There are few studies on scabies in Africa, including Ethiopia, and population-based studies employing primary data are even rarer.20 23 25 37 38 Scabies prevalence estimates for different parts of Ethiopia range from 2.5% to 33.5%.23 However, since most of these studies were conducted either in areas of scabies outbreaks or were secondary analyses on data related with scabies outbreak response activities, their prevalence estimates may not be representative of the remaining parts of the country.23 39 40 In our study, estimated scabies prevalence was 13.4%. We believe this high community prevalence is likely to be, in part, related to the wider ongoing scabies outbreak across Amhara region, first reported in 2015.26 The prevalence is comparable to studies in southern Ethiopia25 37 but lower than estimates from studies elsewhere in the northern parts of the country.23 26 41 This may be a secondary impact of prior single dose ivermectin-only onchocerciasis MDA that had taken place 8 months before the current study.

Only around a third of those diagnosed with scabies had reported seeking care of any kind by the time this data were collected. Similar poor health seeking behaviour have been reported in other studies.18 22 Not seeking care early because of low perceived severity of manifestations, was also found in a study in a Brazilian urban slum.18 Among those who sought care, more than two-thirds reported attending a primary healthcare facility. Even though we could not rule out the effect of social desirability bias (since the data collectors were health workers), the improving physical and financial access to primary health services could have made healthcare facilities the preferred source of care.42 However, services at these primary healthcare facilities may benefit from enhancing quality of care and employing teledermatology.43 Participants reported to the first author that frequent stock-outs of the commonly used cream (permethrin) in many health centres discouraged their attendance. Self-treatment was the second most frequently mentioned source of care. From our anecdotal field observation, people applied local herbs on the lesions.

Nearly two-thirds of the study population had heard about scabies, primarily from family and friends. The now pervasive awareness about scabies is, we suspect, mainly a result of its occurrence as an outbreak. More than half of the study participants in both groups (ie, clinical scabies and no manifestations of scabies) correctly identified ‘prolonged physical contact with a scabies patient’ as a mode of scabies transmission. There remains room for educational interventions, as over a third in each group did not identify this mode of transmission. Local health worker teaching on scabies has focused heavily on personal hygiene. However, reported frequency of bathing was not predictive in our study, and experimental and epidemiological evidence from elsewhere indicates personal body washing is probably unrelated to scabies prevalence.44 A better focus would be to prevent prolonged physical contact with presumed scabies cases (eg, temporary separation of sleeping arrangements for symptomatic individuals), and to treat all contacts once a scabies case is identified. Most participants believed there is treatment for scabies and a comparable number wanted to know more about scabies in general. This presents an opportunity for effective behavioural change communications. Even though we did not use a validated tool to measure attitude, a subtle stigma was associated with scabies patients. This finding was consistent with Trettin et al, where scabies patients reported shame and fear of stigma as scabies was perceived to be associated with poor hygiene and poverty.45 46 Arguably, the present focus on personal hygiene in teachings surrounding scabies may risk contributing to such social stigma against scabies patients.

High scabies prevalence is reported among children in high scabies burden settings, and in a global systematic review by Romani et al47 prevalence was lower in adults than in children in all relevant studies. In our study, though the association between age and scabies was not statistically significant, the majority of the scabies cases were still among people aged <18 years. Household size was a strong predictor; odds of scabies infestation among people living in households with ≥5 members (a household size larger than the national average)48 was high. Similarly, Hegazy et al49 reported that people from households of high crowding index had higher odds of scabies infestation in rural Egypt. Since prolonged physical contact is required for effective scabies transmission, high host density both in households and institutional settings facilitates transmission.50

Conclusion

Scabies prevalence in Ayu Guagusa district is high and crosses the recommended threshold to initiate preventive chemotherapy.51 MDA needs to be initiated as the outbreak can no longer be controlled through standard care.52 Ivermectin MDAs for scabies were first trialled in Oceania in the late 1990s and have proven to be effective at reducing community prevalence.53 Ideally two doses of oral ivermectin (200 µg/kg) should be given 7–14 days apart, with alternative scabicides provided to whom ivermectin is presently not recommended (children weighing <15 kg or <90 cm height; pregnant women; women breast feeding in the first week). MDA rounds should have a minimum of 80% population coverage and conducted annually for 3–5 years, with a stopping threshold of 2% community prevalence.51 Accompanying such MDAs with educational interventions may also help to: (1) increase awareness about modes of scabies transmission; (2) address the subtle stigma attached to scabies and (3) support communities to modify environmental circumstances that facilitate transmission.

Supplementary Material

Reviewer comments
Author's manuscript

Acknowledgments

We thank the field team, healthcare workers from Gimjabet hospital, for conducting data collection and Dr Vasso Anagnostopoulou for supporting data management activities. Awi Zone and Ayu Guagusa District Health office administration provided invaluable background information about the institutions in the health system and for facilitating the field work. We are also grateful to the participants who welcomed our field team into their homes and gave their time for the interview.

Footnotes

Twitter: @yirgurob, @MedVetAcarology, @abebawfekadu, @jackiecassell

Contributors: This study was carried out as part of the work of the NIHR Global Health Research Unit on Neglected Tropical Diseases Phase 1 at Brighton and Sussex Medical School. For clarity we detail contributions using the CRediT Contributor Roles Taxonomy (https://casrai.org/credit/) and provide employment and disciplinary descriptions. Conceptualisation: JM, AF, JAC, GD. Analysis: RY, JM. Investigation: RY, AT, WE. Methodology: RY, JM, AF, JAC, SB, CIJ, GD. Supervision: JM, AF, JAC, GD. Writing – original draft: RY, JM. Visualisation: JM, AT. Writing – review and editing: RY, JM, AF, JAC, AT, SB, CIJ, WE, GD. RY accepts full responsibility for the work and/or the conduct of the study, had access to the data, and controlled the decision to publish.

Funding: 131996). The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care.131996). The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care.131996). The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care.

Competing interests: None declared.

Patient and public involvement: Patients and/or the public were not involved in the design, or conduct, or reporting, or dissemination plans of this research.

Provenance and peer review: Not commissioned; externally peer reviewed.

Supplemental material: This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.

Data availability statement

Data are available upon reasonable request. All data relevant to the study are included in the article or uploaded as supplementary information.

Ethics statements

Patient consent for publication

Consent obtained directly from patient(s).

Ethics approval

The study involved human participants and ethics approval was obtained from Addis Ababa University Institutional Review Board (IRB) (AAUMF 03-008) and Brighton and Sussex Medical School (BSMS) Research Governance and Ethics Committee (RGEC) (ER/BSMS9G1Z/1). Permission was sought from the Ministry of Health (MoH), Amhara regional health Bureau and local administrative heads before commencing field work. Informed consent was requested and received from all adult participants, and assent from minors 15–17 years. Minors <15 years participated in the study once their parents or guardians gave consent. Participants diagnosed with scabies or other diseases were referred to the nearest health centre for further investigation and treatment.

References

  • 1.World Health Organization . Ending the neglected to attain the sustainable development goals. A road map for neglected tropical diseases 2021–2030. Geneva, 2020. Available: https://www.who.int/publications/i/item/9789240010352 [Google Scholar]
  • 2.Engelman D, Martin DL, Hay RJ, et al. Opportunities to investigate the effects of Ivermectin mass drug administration on Scabies. Parasit Vectors 2013;6:106. 10.1186/1756-3305-6-106 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Nagpal S, Sinclair D, Garner P. Has the NTD community neglected evidence-based policy? PLoS Negl Trop Dis 2013;7:e2238. 10.1371/journal.pntd.0002238 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Fuller LC. Epidemiology of Scabies. Curr Opin Infect Dis 2013;26:123–6. 10.1097/QCO.0b013e32835eb851 [DOI] [PubMed] [Google Scholar]
  • 5.Hay RJ, Steer AC, Engelman D, et al. Scabies in the developing world—its prevalence, complications, and management. Clin Microbiol Infect 2012;18:313–23. 10.1111/j.1469-0691.2012.03798.x [DOI] [PubMed] [Google Scholar]
  • 6.Chosidow O. Scabies. N Engl J Med 2006;354:1718–27. 10.1056/NEJMcp052784 [DOI] [PubMed] [Google Scholar]
  • 7.Mellanby K. Scabies in 1976. R Soc Health J 1977;97:32–6, 10.1177/146642407709700112 [DOI] [PubMed] [Google Scholar]
  • 8.Hardy M, Engelman D, Steer A. Scabies: A clinical update. Aust Fam Physician 2017;46:264–8. [PubMed] [Google Scholar]
  • 9.Walton SF, Currie BJ. Problems in diagnosing Scabies, a global disease in human and animal populations. Clin Microbiol Rev 2007;20:268–79. 10.1128/CMR.00042-06 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Zaidi AKM, Thaver D, Ali SA, et al. Pathogens associated with sepsis in newborns and young infants in developing countries. Pediatr Infect Dis J 2009;28:S10–8. 10.1097/INF.0b013e3181958769 [DOI] [PubMed] [Google Scholar]
  • 11.Gao Z, Zhao H, Xia Y, et al. Clinical characteristics and etiologic analysis of Scabies-associated glomerulonephritis. Intern Med 2015;5:1–5. [Google Scholar]
  • 12.Engelman D, Fuller LC, Steer AC, et al. Consensus criteria for the diagnosis of Scabies: A Delphi study of international experts. PLoS Negl Trop Dis 2018;12:e0006549. 10.1371/journal.pntd.0006549 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Karimkhani C, Colombara DV, Drucker AM, et al. The global burden of Scabies: a cross-sectional analysis from the global burden of disease study 2015. Lancet Infect Dis 2017;17:1247–54. 10.1016/S1473-3099(17)30483-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Mellanby K. The development of symptoms, parasitic infection and immunity in human Scabies. Parasitology 1944;35:197–206. 10.1017/S0031182000021612 [DOI] [Google Scholar]
  • 15.Cassell JA, Middleton J, Nalabanda A, et al. Scabies outbreaks in ten care homes for elderly people: a prospective study of clinical features, epidemiology, and treatment outcomes. Lancet Infect Dis 2018;18:894–902. 10.1016/S1473-3099(18)30347-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Richardson NA, Cassell JA, Head MG, et al. Scabies outbreak management in refugee/migrant camps across europe 2014-17: a retrospective qualitative interview study of healthcare staff experiences and perspectives. medRxiv [Preprint]. 10.1101/2021.04.28.21256211 [DOI] [PMC free article] [PubMed]
  • 17.Feldmeier H, Jackson A, Ariza L, et al. The epidemiology of Scabies in an impoverished community in rural Brazil: presence and severity of disease are associated with poor living conditions and illiteracy. J Am Acad Dermatol 2009;60:436–43. 10.1016/j.jaad.2008.11.005 [DOI] [PubMed] [Google Scholar]
  • 18.Heukelbach J, van Haeff E, Rump B, et al. Parasitic skin diseases: health care-seeking in a slum in North-East Brazil. Trop Med Int Health 2003;8:368–73. 10.1046/j.1365-3156.2003.01038.x [DOI] [PubMed] [Google Scholar]
  • 19.Boateng LA, Ghana Southampton Scabies Research Partnership . Healthcare-seeking behaviour in reporting of Scabies and skin infections in Ghana: A review of reported cases. Trans R Soc Trop Med Hyg 2020;114:830–7. 10.1093/trstmh/traa071 [DOI] [PubMed] [Google Scholar]
  • 20.Figueroa JI, Fuller LC, Abraha A, et al. Dermatology in southwestern Ethiopia: rationale for a community approach. Int J Dermatol 1998;37:752–8. 10.1046/j.1365-4362.1998.00425.x [DOI] [PubMed] [Google Scholar]
  • 21.La Vincente S, Kearns T, Connors C, et al. Community management of Endemic Scabies in remote aboriginal communities of northern Australia: low treatment uptake and high ongoing acquisition. PLoS Negl Trop Dis 2009;3:e444. 10.1371/journal.pntd.0000444 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Lopes MJ, da Silva ET, Ca J, et al. Perceptions, attitudes and practices towards Scabies in communities on the Bijagós Islands, guinea-Bissau. Trans R Soc Trop Med Hyg 2020;114:49–56. 10.1093/trstmh/trz102 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Enbiale W, Ayalew A. Investigation of a Scabies outbreak in drought-affected areas in Ethiopia. Trop Med Infect Dis 2018;3:114. 10.3390/tropicalmed3040114 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Yassin ZJ, Dadi AF, Nega HY, et al. “Scabies outbreak investigation among “Yekolo Temaris” in Gondar town, North Western Ethiopia, November 2015”. Electronic J Biol 2017;13:203–9. [Google Scholar]
  • 25.Sara J, Haji Y, Gebretsadik A. Scabies outbreak investigation and risk factors in East Badewacho district, Southern Ethiopia: unmatched case control stud. Dermatol Res Pract 2018;2018:7276938. 10.1155/2018/7276938 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Accorsi S, Barnabas GA, Farese P, et al. Skin disorders and disease profile of poverty: analysis of medical records in Tigray, northern Ethiopia, 2005-2007. Trans R Soc Trop Med Hyg 2009;103:469–75. 10.1016/j.trstmh.2008.11.028 [DOI] [PubMed] [Google Scholar]
  • 27.Figueroa JI, Hawranek T, Abraha A. Prevalence of skin diseases in school children in rural and urban communities in the Illubabor province, South-Western Ethiopia: a preliminary survey. J Europ Acad Dermatol Venereol 1997;9:142–8. 10.1016/S0926-9959(97)00105-0 [DOI] [Google Scholar]
  • 28.Walker SL, Lebas E, De Sario V, et al. The prevalence and association with health-related quality of life of Tungiasis and Scabies in schoolchildren in Southern Ethiopia. PLoS Negl Trop Dis 2017;11:e0005808. 10.1371/journal.pntd.0005808 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Yirgu R, Middleton J, Fekadu A, et al. No secondary impact of Ivermectin mass drug administration for Onchocerciasis elimination on the prevalence of Scabies in northwestern Ethiopia. Trans R Soc Trop Med Hyg 2023:trad061. 10.1093/trstmh/trad061 [DOI] [PubMed] [Google Scholar]
  • 30.Federal Democratic Republic of Ethiopia Ministry of Health . Health sector development programme IV.2000. 2010. Available: http://www.nationalplanningcycles.org/sites/default/files/country_docs/Ethiopia/ethiopia_hsdp_iv_final_draft_2010_-2015.pdf
  • 31.Federal Democratic Repiblic of Ethiopia Population Census Commission . Summary and Statical report of the 2007 Populatin and housing census Addis Ababa. United Nations Population Fund 2008. Available: https://www.statsethiopia.gov.et/census-2007-2/ [Google Scholar]
  • 32.Central Statistics Agency (CSA) . Ethiopia socioeconomic survey. 2019. Available: https://www.statsethiopia.gov.et/
  • 33.Kositz C, Drammeh M, Vasileva H, et al. Effects of Ivermectin mass drug administration for malaria vector control on Ectoparasites and soil-transmitted Helminths: a cluster randomized trial. Int J Infect Dis 2022;125:258–64. 10.1016/j.ijid.2022.10.043 [DOI] [PubMed] [Google Scholar]
  • 34.Regasa MT, Hinkosa L, Besho M, et al. Predictors of Preterm birth in Western Ethiopia: A case control study. PLoS One 2021;16:e0247927. 10.1371/journal.pone.0247927 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Legesse A, Adisalem D. Attitude and practice toward Legalization of abortion among female students of Sabiyan secondary and preparatory school, dire Dawa. Asian J Med Res 2020;9. 10.47009/ajmr.2020.9.2.CM1 [DOI] [Google Scholar]
  • 36.Assefa Y, Gelaw YA, Hill PS, et al. Community health extension program of Ethiopia, 2003–2018: successes and challenges toward universal coverage for primary Healthcare services. Global Health 2019;15:24. 10.1186/s12992-019-0470-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Wochebo W, Haji Y, Asnake S. Scabies outbreak investigation and risk factors in Kechabira district, Southern Ethiopia: unmatched case control study. BMC Res Notes 2019;12:305. 10.1186/s13104-019-4317-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Dagne H, Dessie A, Destaw B, et al. Prevalence and associated factors of Scabies among schoolchildren in Dabat district, Northwest Ethiopia, 2018. Environ Health Prev Med 2019;24:67. 10.1186/s12199-019-0824-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Azene AG, Aragaw AM, Wassie GT. Prevalence and associated factors of Scabies in Ethiopia: systematic review and meta-analysis. BMC Infect Dis 2020;20:380. 10.1186/s12879-020-05106-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Enbiale W, Baynie TB, Ayalew A, et al. “"stopping the itch": mass drug administration for Scabies outbreak control covered for over nine million people in Ethiopia”. J Infect Dev Ctries 2020;14:28S–35S. 10.3855/jidc.11701 [DOI] [PubMed] [Google Scholar]
  • 41.Enbiale W, Ayalew A, Gebrehiwot T, et al. Does mass drug administration for community-based scabies control works? the experience in Ethiopia. J Infect Dev Ctries 2020;14:78S–85S. 10.3855/jidc.11892 [DOI] [PubMed] [Google Scholar]
  • 42.Demissie B, Gutema Negeri K. Effect of community-based health insurance on utilization of outpatient health care services in Southern Ethiopia: A comparative cross-sectional study. Risk Manag Healthc Policy 2020;13:141–53. 10.2147/RMHP.S215836 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Joshi TP, Ren V. Teledermatology in the control of skin neglected tropical diseases: A systematic review. Dermatol Pract Concept 2021;11:e2021130. 10.5826/dpc.1104a130 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Middleton J, Cassell JA, Jones CI, et al. Scabies control: the forgotten role of personal hygiene - authors' reply. Lancet Infect Dis 2018;18:1068–9. 10.1016/S1473-3099(18)30558-9 [DOI] [PubMed] [Google Scholar]
  • 45.Trettin B, Lassen JA, Andersen F, et al. The journey of having Scabies–A qualitative study. JNEP 2019;9:1. 10.5430/jnep.v9n2p1 [DOI] [Google Scholar]
  • 46.Jin-gang A, Sheng-xiang X, Sheng-bin X, et al. Quality of life of patients with Scabies. J Eur Acad Dermatol Venereol 2010;24:1187–91. 10.1111/j.1468-3083.2010.03618.x [DOI] [PubMed] [Google Scholar]
  • 47.Romani L, Whitfeld MJ, Koroivueta J, et al. Mass drug administration for Scabies control in a population with Endemic disease. N Engl J Med 2015;373:2305–13. 10.1056/NEJMoa1500987 [DOI] [PubMed] [Google Scholar]
  • 48.Central Statistical Agency (CSA) Ethiopia and ICF . Ethiopia demographic and health survey 2016. Addis Ababa Ethiopia and Rockville, Maryland, USA. 2016. Available: https://evaw-global-database.unwomen.org/en/countries/africa/ethiopia/2016/demographic-and-health-survey-2016
  • 49.Hegazy AA, Darwish NM, Abdel-Hamid IA, et al. Epidemiology and control of Scabies in an Egyptian village. Int J Dermatol 1999;38:291–5. 10.1046/j.1365-4362.1999.00630.x [DOI] [PubMed] [Google Scholar]
  • 50.Middleton J, Cassell JA, Walker S. Scabies management in institutions. In: Fischer K, Chosidow O, eds. Scabies. Berlin: Springer, 2023. [Google Scholar]
  • 51.World Health Organization . WHO Informal Consultation on a Framework for Scabies Control. Manila, 2019. Available: https://www.who.int/publications/i/item/9789240008069 [Google Scholar]
  • 52.Hotez PJ. Ten failings in global neglected tropical diseases control. PLoS Negl Trop Dis 2017;11:e0005896. 10.1371/journal.pntd.0005896 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Middleton J. Can Ivermectin mass drug administrations to control Scabies also reduce skin and soft tissue infections? hospitalizations and primary care presentations lower after a large-scale trial in Fiji. Lancet Reg Health West Pac 2022;22:100454. 10.1016/j.lanwpc.2022.100454 [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary data

bmjopen-2023-075038supp001.pdf (682.4KB, pdf)

Reviewer comments
Author's manuscript

Data Availability Statement

Data are available upon reasonable request. All data relevant to the study are included in the article or uploaded as supplementary information.


Articles from BMJ Open are provided here courtesy of BMJ Publishing Group

RESOURCES